Tune Therapeutics Funding & Investors
Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.
tunetx.comTotal Amount Raised: $40,000,000
Tune Therapeutics Funding Rounds
Series A
$40,000,000
Series A Investors
Hatteras Venture PartnersSaisei VenturesEmerson CollectiveNew Enterprise Associates (NEA)Mission BioCapital
Funding info provided by Diffbot.